VPRO MUST READ! VIROPRO, INC. SELECTED AS 2010 BRITISH AIRWAYS FACE-OF-OPPORTUNITY WINNER
(They certainly have made "considerable progress" with their recent announcement, and it looks like Full Speed Ahead for a "Global Business Plan!" Looking GREAT here! Good Luck to All, V)
http://www.marketwatch.com/story/viropro-inc-selected-as-2010-british-airways-face-of-opportunity-winner-2010-12-23
Dec 23, 2010 (TheNewswire.ca via COMTEX) -- (via Thenewswire.ca)
New York, Dec. 23, 2010 - VIROPRO, INC., today announced that it has been selected by British Airways as a 2010 Face-of-Opportunity winner and has been awarded travel to anywhere in the world to conduct vital business meetings as well as attend the British Airways Face-of-Opportunity business conference. This award is part of the British Airways Face-to-Face program, which provides small business owners and entrepreneurs the critical tools for building business relationships abroad and stimulating growth through the power of face- to-face interaction.
"We are thrilled to be part of the prestigious group of entrepreneurs that were chosen by British Airways as a Face-of-Opportunity winner," said Dr. Rajiv Datar, President and CEO, of Viropro, Inc. "This flight will give us the chance to meet our (key stakeholders/partners/customers/manufacturers) in 2011, which is vital for the growth of our business in 2011 and beyond."
Dr. Datar adds: "This is the perfect complement to our growing biotech Contract Research, Development and GMP Manufacturing Services offering. Over the last several months we have set in motion our new, global business plan, and have made considerable progress towards its implementation."
Furthermore, Viropro is currently in negotiations for 2 major acquisitions and has recently secured a financial partner for its financing effort to come.
Before taking off, Dr. Datar will attend the British Airways Face-of-Opportunity conference in New York City on Feb. 2, 2011 where the company will receive free counsel from top influential international business experts while networking with venture capitalists, renowned entrepreneurs, media and other small business owners.
The conference, which includes an introduction by Simon Talling-Smith, Executive Vice President Americas, British Airways, and keynote speeches by Rhonda Abrams, best-selling author and USA Today small business columnist and Bill Rancic, best-selling author and first season winner of The Apprentice, will provide VIROPRO, INC. with additional tools in business planning, marketing and travel to assist the company in its strategy to evolve into a premier alternative in the area of biopharmaceutical contract development and manufacturing services.
"We are very excited for this phase of the program and for the 250 small business owners who, beyond the educational resources already provided through the Face-to-Face program, now have the opportunity to fly British Airways overseas to conduct vital face-to-face meetings for their business," said Simon Talling-Smith. "Each of the winner's stories is uniquely inspiring and our hope is that the program is a powerful catalyst in ensuring lasting and fruitful businesses for them."
About Viropro, Inc.:
Viropro, Inc. conducts its operations through its subsidiaries Viropro International, Inc. and Biologics Process Development, Inc. The Company's principal objective and mission is to "make biotech drugs for its clients, efficiently and economically." Towards this end, the Company specializes in the use of its Intellectual Property and high-yield manufacturing process technologies, for industrial-scale production of biopharmaceutical drugs for its clients that serve global markets, with unmet medical- and/or market needs (www.viropro.com).
News 
Market Data 
Discover 
